How to interest and (or) force sponsors (pharmaceutical companies, etc.) to invest in conducting clinical trials in the country?

In our country, the volume of clinical trials is quite low. Despite the favorable conditions (shortening the time for obtaining approval and bureaucratic barriers), the sponsors (represented by...

02 February 2020 3,316 3 View